- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x CA: CALCIUM ION(Non-covalent)
- 5 x DU0: 2-[2-[(1~{S},2~{S},4~{S},5'~{R},6~{R},7~{S},8~{R},9~{S},12~{S},13~{R},16~{S})-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-18-ene-6,2'-oxane]-16-yl]oxyethyl]propane-1,3-diol(Non-covalent)
DU0.2: 12 residues within 4Å:- Chain A: L.46, L.54, G.57, Q.58, Y.61, F.62, L.65, L.249, L.252, I.253
- Ligands: MC3.5, MC3.6
14 PLIP interactions:14 interactions with chain A- Hydrophobic interactions: A:L.46, A:L.46, A:L.54, A:Y.61, A:Y.61, A:F.62, A:L.65, A:L.249, A:L.252, A:I.253
- Hydrogen bonds: A:G.57, A:G.57, A:Y.61
- Water bridges: A:K.64
DU0.15: 12 residues within 4Å:- Chain B: L.46, L.54, G.57, Q.58, Y.61, F.62, L.65, L.249, L.252, I.253
- Ligands: MC3.18, MC3.19
14 PLIP interactions:14 interactions with chain B- Hydrophobic interactions: B:L.46, B:L.46, B:L.54, B:Y.61, B:Y.61, B:F.62, B:L.65, B:L.249, B:L.252, B:I.253
- Hydrogen bonds: B:G.57, B:G.57, B:Y.61
- Water bridges: B:K.64
DU0.28: 12 residues within 4Å:- Chain C: L.46, L.54, G.57, Q.58, Y.61, F.62, L.65, L.249, L.252, I.253
- Ligands: MC3.31, MC3.32
14 PLIP interactions:14 interactions with chain C- Hydrophobic interactions: C:L.46, C:L.46, C:L.54, C:Y.61, C:Y.61, C:F.62, C:L.65, C:L.249, C:L.252, C:I.253
- Hydrogen bonds: C:G.57, C:G.57, C:Y.61
- Water bridges: C:K.64
DU0.39: 12 residues within 4Å:- Chain D: L.46, L.54, G.57, Q.58, Y.61, F.62, L.65, L.249, L.252, I.253
- Ligands: MC3.42, MC3.43
14 PLIP interactions:14 interactions with chain D- Hydrophobic interactions: D:L.46, D:L.46, D:L.54, D:Y.61, D:Y.61, D:F.62, D:L.65, D:L.249, D:L.252, D:I.253
- Hydrogen bonds: D:G.57, D:G.57, D:Y.61
- Water bridges: D:K.64
DU0.52: 12 residues within 4Å:- Chain E: L.46, L.54, G.57, Q.58, Y.61, F.62, L.65, L.249, L.252, I.253
- Ligands: MC3.55, MC3.56
14 PLIP interactions:14 interactions with chain E- Hydrophobic interactions: E:L.46, E:L.46, E:L.54, E:Y.61, E:Y.61, E:F.62, E:L.65, E:L.249, E:L.252, E:I.253
- Hydrogen bonds: E:G.57, E:G.57, E:Y.61
- Water bridges: E:K.64
- 50 x MC3: 1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
MC3.3: 8 residues within 4Å:- Chain A: W.24, W.33, R.34, L.36, L.37, L.40, L.278
- Ligands: MC3.4
Ligand excluded by PLIPMC3.4: 8 residues within 4Å:- Chain A: L.21, L.22, L.23, W.24, R.25, Y.29
- Ligands: MC3.3, MC3.12
Ligand excluded by PLIPMC3.5: 4 residues within 4Å:- Chain A: Y.61, L.65
- Ligands: DU0.2, MC3.36
Ligand excluded by PLIPMC3.6: 3 residues within 4Å:- Chain A: A.45, Q.58
- Ligands: DU0.2
Ligand excluded by PLIPMC3.7: 2 residues within 4Å:- Chain A: A.45
- Ligands: MC3.8
Ligand excluded by PLIPMC3.8: 6 residues within 4Å:- Chain A: G.41, M.44, A.45, F.52
- Ligands: MC3.7, MC3.11
Ligand excluded by PLIPMC3.9: 4 residues within 4Å:- Chain A: R.34, L.37, C.38
- Chain C: F.14
Ligand excluded by PLIPMC3.10: 4 residues within 4Å:- Chain A: D.270, L.271, C.272
- Ligands: MC3.18
Ligand excluded by PLIPMC3.11: 1 residues within 4Å:- Ligands: MC3.8
Ligand excluded by PLIPMC3.12: 16 residues within 4Å:- Chain A: F.14, G.15, S.18, Q.19, L.21, L.22
- Chain B: E.35, C.38, F.39, F.42, Y.245, S.246, F.248, L.249, L.252
- Ligands: MC3.4
Ligand excluded by PLIPMC3.16: 8 residues within 4Å:- Chain B: W.24, W.33, R.34, L.36, L.37, L.40, L.278
- Ligands: MC3.17
Ligand excluded by PLIPMC3.17: 8 residues within 4Å:- Chain B: L.21, L.22, L.23, W.24, R.25, Y.29
- Ligands: MC3.16, MC3.25
Ligand excluded by PLIPMC3.18: 4 residues within 4Å:- Chain B: Y.61, L.65
- Ligands: MC3.10, DU0.15
Ligand excluded by PLIPMC3.19: 3 residues within 4Å:- Chain B: A.45, Q.58
- Ligands: DU0.15
Ligand excluded by PLIPMC3.20: 2 residues within 4Å:- Chain B: A.45
- Ligands: MC3.21
Ligand excluded by PLIPMC3.21: 6 residues within 4Å:- Chain B: G.41, M.44, A.45, F.52
- Ligands: MC3.20, MC3.24
Ligand excluded by PLIPMC3.22: 4 residues within 4Å:- Chain A: F.14
- Chain B: R.34, L.37, C.38
Ligand excluded by PLIPMC3.23: 4 residues within 4Å:- Chain B: D.270, L.271, C.272
- Ligands: MC3.42
Ligand excluded by PLIPMC3.24: 1 residues within 4Å:- Ligands: MC3.21
Ligand excluded by PLIPMC3.25: 16 residues within 4Å:- Chain B: F.14, G.15, S.18, Q.19, L.21, L.22
- Chain D: E.35, C.38, F.39, F.42, Y.245, S.246, F.248, L.249, L.252
- Ligands: MC3.17
Ligand excluded by PLIPMC3.26: 16 residues within 4Å:- Chain A: E.35, C.38, F.39, F.42, Y.245, S.246, F.248, L.249, L.252
- Chain C: F.14, G.15, S.18, Q.19, L.21, L.22
- Ligands: MC3.30
Ligand excluded by PLIPMC3.29: 8 residues within 4Å:- Chain C: W.24, W.33, R.34, L.36, L.37, L.40, L.278
- Ligands: MC3.30
Ligand excluded by PLIPMC3.30: 8 residues within 4Å:- Chain C: L.21, L.22, L.23, W.24, R.25, Y.29
- Ligands: MC3.26, MC3.29
Ligand excluded by PLIPMC3.31: 4 residues within 4Å:- Chain C: Y.61, L.65
- Ligands: DU0.28, MC3.60
Ligand excluded by PLIPMC3.32: 3 residues within 4Å:- Chain C: A.45, Q.58
- Ligands: DU0.28
Ligand excluded by PLIPMC3.33: 2 residues within 4Å:- Chain C: A.45
- Ligands: MC3.34
Ligand excluded by PLIPMC3.34: 6 residues within 4Å:- Chain C: G.41, M.44, A.45, F.52
- Ligands: MC3.33, MC3.37
Ligand excluded by PLIPMC3.35: 4 residues within 4Å:- Chain C: R.34, L.37, C.38
- Chain E: F.14
Ligand excluded by PLIPMC3.36: 4 residues within 4Å:- Chain C: D.270, L.271, C.272
- Ligands: MC3.5
Ligand excluded by PLIPMC3.37: 1 residues within 4Å:- Ligands: MC3.34
Ligand excluded by PLIPMC3.40: 8 residues within 4Å:- Chain D: W.24, W.33, R.34, L.36, L.37, L.40, L.278
- Ligands: MC3.41
Ligand excluded by PLIPMC3.41: 8 residues within 4Å:- Chain D: L.21, L.22, L.23, W.24, R.25, Y.29
- Ligands: MC3.40, MC3.49
Ligand excluded by PLIPMC3.42: 4 residues within 4Å:- Chain D: Y.61, L.65
- Ligands: MC3.23, DU0.39
Ligand excluded by PLIPMC3.43: 3 residues within 4Å:- Chain D: A.45, Q.58
- Ligands: DU0.39
Ligand excluded by PLIPMC3.44: 2 residues within 4Å:- Chain D: A.45
- Ligands: MC3.45
Ligand excluded by PLIPMC3.45: 6 residues within 4Å:- Chain D: G.41, M.44, A.45, F.52
- Ligands: MC3.44, MC3.48
Ligand excluded by PLIPMC3.46: 4 residues within 4Å:- Chain B: F.14
- Chain D: R.34, L.37, C.38
Ligand excluded by PLIPMC3.47: 4 residues within 4Å:- Chain D: D.270, L.271, C.272
- Ligands: MC3.55
Ligand excluded by PLIPMC3.48: 1 residues within 4Å:- Ligands: MC3.45
Ligand excluded by PLIPMC3.49: 16 residues within 4Å:- Chain D: F.14, G.15, S.18, Q.19, L.21, L.22
- Chain E: E.35, C.38, F.39, F.42, Y.245, S.246, F.248, L.249, L.252
- Ligands: MC3.41
Ligand excluded by PLIPMC3.50: 16 residues within 4Å:- Chain C: E.35, C.38, F.39, F.42, Y.245, S.246, F.248, L.249, L.252
- Chain E: F.14, G.15, S.18, Q.19, L.21, L.22
- Ligands: MC3.54
Ligand excluded by PLIPMC3.53: 8 residues within 4Å:- Chain E: W.24, W.33, R.34, L.36, L.37, L.40, L.278
- Ligands: MC3.54
Ligand excluded by PLIPMC3.54: 8 residues within 4Å:- Chain E: L.21, L.22, L.23, W.24, R.25, Y.29
- Ligands: MC3.50, MC3.53
Ligand excluded by PLIPMC3.55: 4 residues within 4Å:- Chain E: Y.61, L.65
- Ligands: MC3.47, DU0.52
Ligand excluded by PLIPMC3.56: 3 residues within 4Å:- Chain E: A.45, Q.58
- Ligands: DU0.52
Ligand excluded by PLIPMC3.57: 2 residues within 4Å:- Chain E: A.45
- Ligands: MC3.58
Ligand excluded by PLIPMC3.58: 6 residues within 4Å:- Chain E: G.41, M.44, A.45, F.52
- Ligands: MC3.57, MC3.61
Ligand excluded by PLIPMC3.59: 4 residues within 4Å:- Chain D: F.14
- Chain E: R.34, L.37, C.38
Ligand excluded by PLIPMC3.60: 4 residues within 4Å:- Chain E: D.270, L.271, C.272
- Ligands: MC3.31
Ligand excluded by PLIPMC3.61: 1 residues within 4Å:- Ligands: MC3.58
Ligand excluded by PLIP- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Owji, A.P. et al., Structures and gating mechanisms of human bestrophin anion channels. Nat Commun (2022)
- Release Date
- 2022-07-13
- Peptides
- Bestrophin-2: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
ED
CE
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x CA: CALCIUM ION(Non-covalent)
- 5 x DU0: 2-[2-[(1~{S},2~{S},4~{S},5'~{R},6~{R},7~{S},8~{R},9~{S},12~{S},13~{R},16~{S})-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-18-ene-6,2'-oxane]-16-yl]oxyethyl]propane-1,3-diol(Non-covalent)
- 50 x MC3: 1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Owji, A.P. et al., Structures and gating mechanisms of human bestrophin anion channels. Nat Commun (2022)
- Release Date
- 2022-07-13
- Peptides
- Bestrophin-2: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
ED
CE
D - Membrane
-
We predict this structure to be a membrane protein.